Publication | Closed Access

IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway

MedicineReceptor Tyrosine KinaseIdo MetaboliteImmune RegulationImmunologyImmunologic MechanismSurface ExpressionNk CellsCell BiologyCell Signaling